A preliminary placebo-controlled trial of selegiline hydrochloride for smoking cessation (Q44290887)

1 December 2017

A preliminary placebo-controlled trial of selegiline hydrochloride for smoking cessation (English)

1 reference

1 December 2017

1 reference

placebo-controlled trial

1 reference

Tony P George

1

1 reference

1 December 2017

Jennifer C Vessicchio

2

1 reference

1 December 2017

Angelo Termine

3

1 reference

1 December 2017

Peter I Jatlow

4

1 reference

1 December 2017

Thomas R Kosten

5

1 reference

1 December 2017

Stephanie S O'Malley

6

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

1 December 2017

Biological Psychiatry

1 reference

1 December 2017

53

1 reference

1 December 2017

2

1 reference

1 December 2017

136-143

1 reference

Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders

1 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901454-3

Selegiline effects on cocaine-induced changes in medial temporal lobe metabolism and subjective ratings of euphoria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901454-3

A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901454-3

Survival probabilities (the Kaplan-Meier method).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901454-3

Major depression following smoking cessation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901454-3

Doxepin as an adjunct to smoking cessation: a double-blind pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901454-3

Slow recovery of human brain MAO B after L-deprenyl (Selegeline) withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901454-3

Inhibition of monoamine oxidase B in the brains of smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901454-3

Brain monoamine oxidase A inhibition in cigarette smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901454-3

Effects of nicotine withdrawal on central dopaminergic systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901454-3

Effects of repeated nicotine pre-treatment on mesoprefrontal dopaminergic and behavioral responses to acute footshock stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901454-3

Effects of repeated nicotine administration and footshock stress on rat mesoprefrontal dopamine systems: Evidence for opioid mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901454-3

A placebo controlled trial of bupropion for smoking cessation in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901454-3

Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901454-3

Cigarette smoking: implications for psychiatric illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901454-3

Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901454-3

Smoking, smoking cessation, and major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901454-3

Statistical analysis of randomized trials in tobacco treatment: longitudinal designs with dichotomous outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901454-3

Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901454-3

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901454-3

Recent advances in the pharmacotherapy of smoking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901454-3

Prevalence of smoking among psychiatric outpatients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901454-3

A comparison of sustained-release bupropion and placebo for smoking cessation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901454-3

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901454-3

Does selegiline modify the progression of early Parkinson's disease? Results from a five-year study. The Norwegian-Danish Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901454-3

Clinical pharmacokinetics and pharmacodynamics of selegiline. An update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901454-3

Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901454-3

Monoamine oxidase and catechol-O-methyltransferase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901454-3

Reliability of a Timeline Method: assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901454-3

The development and initial validation of a questionnaire on smoking urges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901454-3

Changes in urinary catecholamine excretion after smoking cessation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901454-3

Smoking and mental illness: A population-based prevalence study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901454-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(02)01454-3

1 reference

1 December 2017

1 reference